Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,909 | 77,605 | 24,194 | 162,636 | 55,389 |
| Marketable Securities | N/A | N/A | 27,802 | 0 | N/A |
| Receivables | N/A | N/A | N/A | 24,493 | N/A |
| TOTAL | $23,825 | $80,471 | $54,592 | $205,605 | $62,867 |
| Non-Current Assets | |||||
| PPE Net | 4,385 | 6,764 | 8,628 | 43 | 123 |
| Intangibles | 0 | 0 | 0 | 27,764 | 59,464 |
| Other Non-Current Assets | 2,248 | 2,319 | 8,933 | 7,335 | 369 |
| TOTAL | $6,633 | $9,083 | $17,561 | $35,142 | $59,956 |
| Total Assets | $30,458 | $89,554 | $72,153 | $240,747 | $122,823 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,081 | 3,933 | 1,728 | 2,853 | 3,102 |
| Accrued Expenses | 7,448 | 7,662 | 10,361 | 8,255 | 3,973 |
| Other current liabilities | 1,060 | 965 | 523 | 460 | 9,474 |
| TOTAL | $16,055 | $15,908 | $19,670 | $11,568 | $18,049 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 33,717 | N/A | N/A |
| Deferred Revenues | 3,729 | 1,413 | 2,459 | N/A | 1,500 |
| Other Non-Current Liabilities | 1,042 | 1,786 | 115,564 | 52,000 | 99,973 |
| TOTAL | $42,312 | $47,114 | $195,153 | $57,469 | $114,001 |
| Total Liabilities | $58,367 | $63,022 | $214,823 | $69,037 | $132,050 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,788 | 41,543 | 10,175 | 9,973 | 8,379 |
| Common Shares | 41 | 40 | 2 | 199 | 140 |
| Retained earnings | -305,579 | -245,102 | -158,223 | -316,257 | -315,921 |
| Other shareholders' equity | 0 | 0 | 14,354 | 0 | 0 |
| TOTAL | $-27,909 | $26,532 | $-142,670 | $171,710 | $-9,227 |
| Total Liabilities And Equity | $30,458 | $89,554 | $72,153 | $240,747 | $122,823 |